N1 Single lymph node metastasis, 2 cm or less in greatest ... The subtypes investigated in bladder cancer were CK19, CK20 and CK7 IHC/RT-PCR CK20: 56–46% [98,99]; CK7: 100% [99]; CK1: 93.1% ...

Discover real-world data showing that only a minority of patients complete the recommended 4–6 chemotherapy cycles in bladder ...

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin and cisplatin in advanced or metastatic bladder cancer: results of a large, randomised, multinational, multicenter phase III ...

However, just under one in 10 patients are found to have advanced or metastatic bladder cancer, which has not just penetrated ...

Bladder cancer affects over 52,000 men and women in the United States on an annual basis, and more than 12,000 people die each year from this disease. It is the fourth most common cancer in men in ...

Approximately 10,500 people in the UK are diagnosed with bladder cancer every year, which equates to 29 people per day. Around 20 percent of people with advanced or metastatic bladder cancer have ...

More than one third of patients receiving first-line chemotherapy for metastatic bladder cancer did not have guideline-recommended treatment adherence.